InspireMD announces CE Mark approval for CGuard Prime EPS

InspireMD (NSPR) announced the company has received CE Mark approval under the European Medical Device Regulation for the CGuard Prime EPS. CGuard Prime was developed incorporating extensive user feedback and optimizes deliverability and deployment of the proven CGuard stent. With its proprietary MicroNet mesh, CGuard is designed to reduce both early and late embolic events by trapping debris against the vessel wall, preventing plaque prolapse and embolization that can cause stroke.